Primary Site >> Biliary tract Cancer
Gene >> ERCC1
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer. PMID: 20955617 |
Ref: ERCC1 (excision repair cross-complementing 1) expression in pT2 gallbladder cancer is a prognostic factor. PMID: 21117025 |
Ref: Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy. PMID: 22760605 Ref: ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma. PMID: 23613672 |
Ref: ERCC1 in advanced biliary tract cancer patients treated with chemotherapy: prognostic and predictive roles. PMID: 24326865 Ref: ERCC1 mRNA expression as a postoperative prognostic marker in extrahepatic bile duct cancer. PMID: 24763983 |
Ref: Prognostic Value of Excision Repair Cross-Complementing Gene 1, Dihydropyrimidine Dehydrogenase, and Human Equilibrative Nucleotide Transporter 1 Expression and Their Implications for Adjuvant Treatment in Patients With Ampullary Carcinoma. PMID: 25906447 |
Ref: Predictive and prognostic values of ERCC1 and XRCC1 in biliary tract cancers. PMID: 26763622 |
Ref: Prevalence of CTR1 and ERCC1 Polymorphisms and Response of Biliary Tract Cancer to Gemcitabine-Platinum Chemotherapy PMID: 28443323 |